WITHDRAWN: Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma

Benjamin J Van Treeck; Maria C Olave; Ryan D Watkins; Haiyan Lu; Roger K Moreira; Taofic Mounajjed; Michael J Johnson; Carin Y Smith; Sumera I Ilyas; Nguyen H Tran; Sarah M Jenkins; Katelyn A Reed; Rory Smoot; Amit Mahipal; Daniela Allende; Rondell P Graham

doi:10.1016/j.hpb.2024.04.011

WITHDRAWN: Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma

HPB (Oxford). 2024 Apr 24:S1365-182X(24)01277-2. doi: 10.1016/j.hpb.2024.04.011. Online ahead of print.

Authors

Benjamin J Van Treeck¹, Maria C Olave¹, Ryan D Watkins², Haiyan Lu³, Roger K Moreira¹, Taofic Mounajjed¹, Michael J Johnson¹, Carin Y Smith⁴, Sumera I Ilyas⁵, Nguyen H Tran⁶, Sarah M Jenkins⁴, Katelyn A Reed¹, Rory Smoot², Amit Mahipal⁷, Daniela Allende³, Rondell P Graham⁸

Affiliations

¹ Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN, USA.
² Mayo Clinic, Department of Surgery, Department of Biochemistry and Molecular Biology, Rochester, MN, USA.
³ Cleveland Clinic, Department of Pathology, Cleveland, OH, USA.
⁴ Mayo Clinic, Department of Quantitative Health Sciences, Rochester, MN, USA.
⁵ Mayo Clinic, Division of Gastroenterology and Hepatology, Department of Immunology, Rochester, MN, USA.
⁶ Mayo Clinic, Department of Oncology, Rochester, MN, USA.
⁷ Mayo Clinic, Department of Oncology, Rochester, MN, USA; University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
⁸ Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN, USA. Electronic address: [email protected].

PMID: 38789383
DOI: 10.1016/j.hpb.2024.04.011

Abstract

The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.hpb.2024.04.011. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal.